Aeglea Competitors and Similar CompaniesClear all
Aeglea's competitors and similar companies include PHAXIAM Therapeutics and Aptevo Therapeutics.
 Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors. |  Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. | |
Founding Date | Founding Date 2013 | Founding Date 2004 | Founding Date 2016 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Austin, US HQ | Locations Lyon, FR HQ Cambridge, US Princeton, US | Locations Seattle, US HQ |
Employees | Employees 65117% increase | Employees 49 | Employees 1182% decrease |
Valuation ($) | Valuation ($) 48.6 m | Valuation ($) 52.8 m | Valuation ($) 4.1 m |
Financial | |||
Net income | Net income ($155.2m) (FY, 2025) | Net income (€23.5m) (FY, 2023) | Net income ($26m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
PHAXIAM Therapeutics
HQ
Lyon, FR
Employees
49
PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors.
View companyAptevo Therapeutics
HQ
Seattle, US
Employees
118↓ 2% decrease
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
View company